Skip to content

Sleep in Collegiate Baseball Players

Assessing and Optimizing Sleep, Diet, and Performance in Columbia University Baseball Players

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07212101
Enrollment
38
Registered
2025-10-08
Start date
2025-09-16
Completion date
2025-10-31
Last updated
2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Brief summary

Sleep is an essential biological function that impacts nearly every aspect of an athlete's physical and mental health. For athletes, the importance of high-quality sleep cannot be overstated, as it plays a critical role in performance, recovery, and overall well-being. Sleep supports muscle recovery by promoting protein synthesis and the release of growth hormones, essential for healing after intense physical exertion. Furthermore, adequate sleep is crucial for maintaining cognitive sharpness, decision-making abilities, and emotional regulation-all of which are necessary for optimal athletic performance. The study will assess both sleep quality and quantity in baseball players at Columbia University. These tools will help quantify key sleep metrics, including sleep duration, latency (the time it takes to fall asleep), and the number of awakenings during the night. Similarly, the study will analyze dietary patterns using the Automated Self-Administered 24-Hour Dietary Assessment (ASA24), tracking nutrient intake, meal timing, and the consumption of ultra-processed foods. These assessments will establish a baseline from which to measure improvement post-intervention. The intervention will focus on improving diet, time in bed, and light exposure to improve sleep, diet, and performance in collegiate baseball athletes.

Interventions

BEHAVIORALSleep and diet

Participants will be asked to increase their fruit and vegetable consumption, time in bed, and modify light exposure across the day

Sponsors

University of Arizona
CollaboratorOTHER
Idorsia Pharmaceuticals Ltd.
CollaboratorINDUSTRY
Oura Ring
CollaboratorUNKNOWN
Columbia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Single group intervention evaluating outcomes pre and post intervention

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Collegiate baseball player at Columbia University

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Dietary qualitypre and post intervention (4-6 weeks)3-day food recalls (ASA-24)
Sleep qualityNightly for 6 weeksSleep stage (%REM, %Deep sleep)
Athletic performance (position-specific for batters and pitchers)pre and post intervention (4-6 weeks)Batters: Baseball radar gun, outcome is exit velocity (speed at which ball leaves the bat, in miles/h) Pitchers: Baseball radar gun measuring velocity (miles/h)

Secondary

MeasureTime frameDescription
Generalized Anxiety Disorder (GAD-7)pre and post intervention (4-6 weeks)7 questions, 0-3 points each (not at all to nearly every day); global score 0-21, higher score is worse
Sport Anxiety Scale-2pre and post intervention (4-6 weeks)4-point Likert scale (not at all to very much); global score 5-20, higher score is worse
Pitching accuracypre and post intervention (4-6 weeks)Ratio of strikes to balls (pitchers only)
Isometric wall pushpre and post intervention (4-6 weeks)Hand-held dynamometer (pounds) (pitchers only)
Patient Health Questionnaire-9pre and post intervention (4-6 weeks)9 questions, 0-3 points each (not at all to nearly every day); global score 0-27, higher score is worse

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026